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The aim of this study was to compare two extraction procedures: dynamic headspace-purge and trap 
(PT) and headspace solid-phase microextraction (HS-SPME) for gas chromatographic determination of 
benzene, toluene, ethylbenzene, and isomeric xylenes (BTEX) in urine with photoionization (PID) and 
mass spectrometric (MS) detection, respectively. Both methods showed linearity in the range of interest 
[(50-2000) ng L-1], good accuracy (80% to 100 %), and repeatability (RSD≤11 %). Detection limits were 
in the low ng L-1 level for both methods, although slightly greater sensitivity was found for the PT method. 
In comparison with PT, HS-SPME was simpler and required less time for analysis.
Although the analytical features of both examined methods are appropriate for biomonitoring of 
environmental exposure to BTEX, only the HS-SPME-GC-MS method is recommended for routine analysis 
of BTEX in urine. The method was applied for the quantitative analysis of BTEX in urine samples collected 
from non-smokers (n=10) and smokers (n=10).
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Benzene, toluene, ethylbenzene, m-, p-, and o-
xylene (BTEX) are ubiquitous pollutants of the indoor 
and outdoor human environment. Two main sources 
of these compounds are traffic and tobacco smoking 
(1). BTEX are widely used in the manufacture of paints, 
synthetic rubber, agricultural chemicals and chemical 
intermediates (2). BTEX are hazardous carcinogenic 
and neurotoxic compounds, and are classified as 
priority pollutants by the US Environmental Protection 
Agency (EPA), in particular benzene, which the 
International Agency for Research on Cancer (IARC) 
classified as a carcinogen in humans (3).
In non-occupational exposure BTEX were usually 
analysed in blood (4-7) or exhaled breath (8). With 
development of more sensitive analytical techniques, 
analysis of those compounds in the urine has become 
the method of choice due to simplicity and non-
invasive sample collection. Since it is not known for 
BTEX to occur in human urine as a result of normal 
physiological metabolism, the finding of measurable 
concentrations of BTEX in the urine should reflect 
exposure to these aromatic compounds. At the level 
of environmental exposure, the concentration of BTEX 
excreted unmodified in the urine is low; the proportion 
is usually in the order of 1 % or less of the absorbed 
dose (9), so the quantification of BTEX in the urine 
of general population has become possible thanks 
to the development of the very sensitive analytical 
techniques which permit determination at levels as 
low as ng L-1 (1, 5, 10). Several instrumental variations 
are described for the low level BTEX determinations in 
the urine. These include different sampling techniques 
such as dynamic headspace (thermal desorption, 
TD and purge and trap, PT) (10-12) and headspace 
solid-phase microextraction (HS-SPME) (1, 5, 13) 
followed by gas chromatographic separation and 
422
flame ionization (10-12) and/or mass spectrometric 
(1, 5, 10, 13) detection.
Headspace sampling (HS) is suitable for BTEX 
determination in the urine because of their volatility. 
This technique can be performed in a static or a 
dynamic way. Static headspace involves sampling 
gas phase aliquot over the sample using a gas tight 
syringe after equilibration in a sealed vial. Dynamic 
headspace enriches volatiles caught by a cold trap 
or an inert support (e.g. Tenax), by stripping them 
continuously with an inert gas flow through the 
sample. Headspace solid-phase microextraction, 
developed by Zhang and Pawliszyn (14) to evaluate 
volatile compounds from water, is an advancement 
in the static headspace approach. With this sampling 
technique, volatile substances from the headspace of 
sample are adsorbed and concentrated onto a fused-
silica fibre coated with a thin layer of a selective coating 
[usually 100 µm of polydimethylsiloxane (PDMS) for 
BTEX].
The aim of this study was to compare BTEX 
extraction using PT and HS-SPME, and to find out 
which of the two procedures could be recommended 
for routine BTEX analysis in the urine. HS-SPME was 
applied for the quantitative analysis of BTEX in the 
urine samples collected from 20 healthy adults without 
any known occupational BTEX exposure.
MATERIALS, METHODS, AND SUBJECTS
Materials
Benzene, toluene, ethylbenzene, o-, m-, p-xylene, 
and methanol were analytical-grade-purity products 
of Merck (Darmstadt, Germany). Standard reference 
material for BTEX with 2000 µg of each compound 
per mL of methanol was purchased from Supelco 
(Bellefonte, USA) and an aqueous emulsion (30 %) 
of Antifoam A concentrate from Sigma Chemical 
(St. Louis, USA). Headspace vials (6 mL) with PTFE 
septum and holed aluminium caps, hand crimper, 
and decapper were obtained from Varian (Harbor 
City, USA).
Standard Preparation
Stock solutions were prepared by two serial dilution 
steps in methanol. Stock solution A was prepared by 
spiking 3 µL of each analyte to 10 mL of methanol. 
Stock solution B was prepared by dilution of 150 µL 
of stock A to 10 mL of methanol for the PT method, 
and 50 µL of stock A to 10 mL of methanol for HS-
SPME. Working standards were prepared by spiking 
known amounts of stock B into deionized water, 
purified under a stream of dry nitrogen at 50 °C for 
4 hours. One hundred µL of working standards were 
added to 9.9 mL of blank urine for the PT method and 
to 0.9 mL of blank urine for the HS-SPME method. 
The stock solutions were kept at -20 °C, and working 
standards were freshly prepared every day.
The urine used for standard preparation was 
collected from non-smoking, occupationally non-
exposed donors. Pooled urine was analysed before 
spiking, and the calibration curves were corrected for 
its BTEX content.
The samples prepared using the PT procedure 
were analysed by gas chromatography (GC) with 
photoionization detection (PID) and those prepared 
using the HS-SPME procedure by gas chromatography-
mass spectrometry (GC-MS).
PT-GC-PID procedure
The purge vessel containing 10 mL of urine and 
(0.5-1.0) mg of lyophilisated antifoam A was flushed 
with helium for 10 minutes at room temperature 
(21 °C) to purge volatile components. These 
components were transferred by carrier gas (helium) 
to a fused silica trap, and cooled to -100 °C by liquid 
nitrogen. After the refocusing of components, the 
cold trap was flash-heated (200 °C for 1 min), and the 
components were injected onto the Rtx-624 (Restek, 
Bellefonte, USA) capillary column (60 m x 0.32 mm 
I.D., 1.8 µm film thickness) where they were separated. 
We used a Varian 3800 gas chromatograph, equipped 
with a CP-4010 Purge and Trap Injector (PTI), Thermal 
Desorption Cold Trap Injector (TCT) (Chrompack, 
Middleburg, Netherlands), and photoionization 
detector (Varian, Walnut Creek, CA, USA). After 
injection, the column temperature was programmed 
to maintain at 70 °C for the first 10 min, then rise 
to 150 °C at the rate of 6 °C min-1 and maintain this 
temperature for 4 min, then again rise to 200 °C at the 
rate of 30 °C min-1 and maintain this temperature for 
another 3 min. The flow rate of the carrier gas (helium) 
was 1 mL min-1. The make-up gas (nitrogen) flow was 
29 mL min-1. The detector temperature was 230 °C. 
This method has been described earlier (12).
HS-SPME-GC-MS procedure
Clear glass vials (6 mL) with a stir bar were filled 
with 1 mL of urine, sealed with PTFE septum and 
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holed aluminium caps. The vials were equilibrated 
at room temperature (21 °C) for 30 min. Fused 
silica fibre 10 mm long, coated with a 100 µm thick 
PDMS film was used (Supelco, Bellefonte, USA). 
The fibre was exposed to the headspace above the 
sample for 15 min at room temperature (21 °C). 
During the extraction, the urine sample was stirred 
(300 rpm). After the extraction, the fibre was pulled 
in the stainless steel needle and inserted into the SPI 
injector (septum-equipped programmable injector). 
Analytes were thermally desorbed from the SPME 
fibre at 200 °C for 3 min and analysed using a Varian 
3400 CX gas chromatograph with Saturn ion trap 
mass spectrometer operating in the electron impact 
(EI) mode. The components were injected onto the 
Rtx-5 (Restek, Bellefonte, USA) capillary column (30 
m x 0.25 mm I.D., 0.25 µm film thickness). The oven 
temperature was kept at 35 °C for 2 min, and then the 
temperature was raised to 90 °C at 5 °C min-1. Late-
eluating compounds were removed by increasing the 
temperature to 300 °C at 50 °C min-1. The flow rate 
of helium carrier gas was 1 mL min-1. The delay time 
was 2 min. Monitored ions were m/z 78 (benzene) and 
91 (toluene, ethylbenzene, and xylenes).
Analytical Validation
Calibration curves were obtained by analysing urine 
spiked with (50-2000) ng L-1 of BTEX. Least-squares 
linear regression analysis was used to estimate the 
slopes (b) and intercepts (a) of calibration curves 
y=bx+a, where y is the chromatographic area of 
the analyte, and x is the concentration of the analyte 
in urine (ng L-1).
The detection limit (DL) for each analysed 
aromatic hydrocarbon was calculated according to 
the equation: 
DL=(3 SEa+a)/b
where SEa is the standard error of the intercept 
(15).
The accuracy of the methods was obtained from 
six replicate analyses of urine samples spiked with 
100 ng L-1 and 600 ng L-1 of BTEX using the reference 
standard.
The precision of the methods was expressed as 
relative standard deviation, RSD %. The repeatability 
was also estimated from six replicate analyses of 
urine samples spiked with 100 ng L-1 and 600 ng L-1
of BTEX. 
Subjects and urine sampling
BTEX were determined in 20 urine samples from 
healthy adults (10 non-smokers and 10 smokers) 
without any known occupational BTEX exposure. 
Median age of the subjects was 33 years, and 60 % 
were women.
The first urine samples were collected in the 
morning in clean 80-mL bottles, filled completely to 
avoid losses to the headspace and analysed on the day 
of collection using the HS-SPME-GC-MS procedure 
described above.
This study has been approved by the ethical 
committee of the Institute for Medical Research 
and Occupational Health, and has been performed 
according to the Declaration of Helsinki.
Statistics
We performed all statistical analyses using 
Statistica for Windows, release 5.5 (StatSoft Inc., 
Tulsa, Oklahoma, USA). The results within groups are 
presented as median and range, and the significance 
of the difference between groups was calculated 
by using the Mann-Whitney U test. Undetectable 
concentrations were set at 0.5xDL.
RESULTS AND DISCUSSION
Figure 1 shows PT-GC-PID chromatogram of 
blank urine spiked with 800 ng L-1 of BTEX. Total ion 
current and single ion chromatograms obtained by 
HS-SPME-GC-MS, shown in Figure 2, correspond to 
the blank urine spiked with the same concentration of 
BTEX (800 ng L-1). Both described methods allowed 
separation and sensitive determination of BTEX in 
urine. The obtained peaks were sharp, narrow, and 
well separated from impurity peaks because of the 
pre-concentration step. Under the used experimental 
conditions, it was not possible to resolve m- and 
p-xylene and consequently they were calculated 
together. As the photoionization detector is not 
sensitive enough for the HS-SPME analysis of BTEX 
Figure 1 Chromatogram of blank urine spiked with 800 ng L-1 of BTEX 
and analysed using the PT-GC-PID procedure.
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in the urine at the concentration level resulting from 
environmental exposure, a mass spectrometer was 
used as a detector for HS-SPME analysis.
Table 1 summarises the calculated DL, accuracy, 
and repeatability for the determination of BTEX in the 
urine by both methods. Calibration curves were linear 
over the concentration range (50-2000) ng L-1 with 
correlation coefficients >0.998 for both methods. The 
calculated DL ranged between 15 ng L-1 (for toluene) 
and 35 ng L-1 (for ethylbenzene) for PT-GC-PID, and 
between 39 ng L-1 (for toluene) and 50 ng L-1 (for 
benzene) for HS-SPME-GC-MS. According to our 
results, PT-GC-PID had 1.4 to 2 times lower DLs than 
HS-SPME, except for ethylbenzene, where the same 
DLs were calculated for both methods. We obtained 
lower DLs for PT-GC-PID than Fustinoni et al. (11) 
who used the same extraction method. Andreoli et al.
(5) and Fustinoni et al. (1) obtained lower DLs than we 
did, using the same extraction method (HS-SPME), 
but our calculated DLs were significantly lower than 
those calculated by Krämer-Alkade et al. (16).
Accuracy for both methods was similar and greater 
than those previously reported (10, 11, 16). Relative 
standard deviations at the two BTEX concentrations 
were also similar: RSD≤11 % and ≤10 % for HS-
SPME-GC-MS and PT-GC-PID, respectively. They 
are comparable with repeatability studies reported 
by Fustinoni et al. (1) and Andreoli et al. (5) using 
HS-SPME-GC-MS and lower than Fustinoni et al. (11) 
using PT-GC-PID.
The use of an antifoam agent is critical in the 
PT analysis to prevent urine from foaming. We used 
Antifoam A and found that obligatory purification by 
lyophilisation after heating antifoam agent under a 
stream of dry nitrogen is absolutely needed, which 
makes PT analysis impractical. Besides, the PT 
method has more drawbacks: it requires complex and 
expensive instrumentation, it is time-consuming, and 
not suitable for routine analyses.
The sensitivity of HS-SPME-GC-MS was good 
enough for BTEX determination in the urine samples 
collected from the general population. Table 2 
summarises mass concentrations of BTEX in the 
urine of 10 non-smokers and 10 smokers. Earlier 
findings showed no need for creatinine correction of 
BTEX in the urine (17). BTEX were measurable in all 
samples, except for benzene in one sample, and o-
xylene in four samples. Toluene had the highest and 
o-xylene the lowest urinary concentration among the 
solvents studied. Smokers had significantly higher 
urinary BTEX concentrations than non-smokers. Our 
results were similar to those reported by others (5, 
7, 10, 13). The exception in our study was toluene, 
Figure 2 Total ion current and selected ion chromatograms of: (1) 
benzene (m/z 78), (2) toluene (m/z 91), (3) ethylbenzene (m/z 
91), (4) m/p-xylene (m/z 91), and (5) o-xylene (m/z 91) in blank 
urine spiked with 800 ng L-1 of BTEX and analysed using the 
HS-SPME-GC-MS procedure.
Table 1 Analytical parameters of PT-GC-PID and HS-SPME-GC-MS determination of BTEX at compound mass concentrations in the urine of 




limit / ng L-1
Accuracy / %
Repeatability 






















Benzene 25 85 99 8 2 50 91 100 11 3
Toluene 15 80 98 10 1 39 94 100 8 2
Ethylbenzene 35 87 100 10 2 35 98 98 10 3
m/p-Xylene 26 95 100 3 0.2 42 97 98 5 4
o-Xylene 30 94 99 10 3 42 96 96 8 5
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which occurred in concentrations lower than those 
measured by Perbellini et al. (7) and Hung et al. (10). 
Our results were, however, higher than those reported 
in our previous study (17), probably due to a difference 
in sampling time; in this study we collected samples in 
the winter, and in the earlier study in the summer when 
lower concentrations of BTEX in air (affecting BTEX 
concentration in urine) were found because of reduced 
heating and enhanced photochemical degradation 
during the summer. In addition, general population 
spend more time inside the house during the winter 
and it is well known that indoor air concentrations of 
BTEX frequently exceed those outdoors (6).
CONCLUSIONS
Both methods showed very good repeatability, 
linearity and accuracy within the range studied. In 
addition, both methods are solvent-free, and do 
not require sample preparation. Extraction and 
preconcentration of BTEX are carried out in a single 
step, and detection limits in the range of ng L-1 
are easily achieved. The cost of the PT system is 
relatively high, and handling during analysis is much 
more complicated than for HS-SPME. Furthermore, 
retention times may vary because of pressure 
changes within the PT system. The main advantage 
of HS-SPME is that it is simple to use, and needs less 
complex instrumentation than PT, but it also requires 
immediate GC analysis of the volatile compounds. The 
shorter time required for the whole analytical process 
(32 min versus 45 min for PT), small sample volume 
(1 mL versus 10 mL for PT), and simple handling 
could be good reasons to recommend HS-SPME for 
routine analysis of BTEX in urine.
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Sa`etak
USPOREDBA DINAMI^KE ANALIZE PARA IZNAD OTOPINE I MIKROEKSTRAKCIJE ANALITA NA 
^VRSTOJ FAZI ZA PLINSKOKROMATOGRAFSKO ODRE\IVANJE BTEX-a U URINU
Cilj ovog rada bio je usporediti dva postupka ekstrakcije za plinskokromatografsko odre|ivanje benzena, 
toluena, etilbenzena i izomera ksilena u urinu. Uspore|ene su dinami~ka analiza para iznad otopine (tzv. 
purge and trap) uz fotoionizacijski detektor i mikroekstrakcija analita na ~vrstoj fazi uz detektor spektrometar 
masa. Rezultati upu}uju na linearnost odziva detektora u ispitivanome koncentracijskom podru~ju [(50-
2000) ng L-1], zadovoljavaju}u to~nost (80 %-100 %) i ponovljivost (RSD ≤11 %). Postignute su niske 
granice detekcije za obje metode. Mikroekstrakcija analita na ~vrstoj fazi uz detektor spektrometar masa 
pokazala se jednostavnijom i br`om za izvo|enje pa se preporu~uje za rutinsko odre|ivanje BTEX-a u urinu. 
Metoda je primijenjena za analizu tih spojeva u uzorcima urina nepu{a~a (n=10) i pu{a~a (n=10).
KLJU^NE RIJE^I: GC-MS, PID, ponovljivost, PT, SPME, to~nost
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